INVESTINGAstraZeneca Gets $1B From U.S. Government for Coronavirus VaccineBy M. Corey GoldmanMay 21, 2020 10:10 AM EDT
PRESS RELEASESFinal PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival In Men With Non-Metastatic Castration-Resistant Prostate CancerBy PR Newswire9 hours ago
PRESS RELEASESXTANDI® (enzalutamide) Approved By Japan MHLW For The Treatment Of Prostate Cancer With Distant MetastasisBy PR Newswire14 hours ago
PRESS RELEASESCorning And Pfizer Announce Supply Agreement For Corning Valor® Glass PackagingBy GlobeNewswireMay 28, 2020 8:30 AM EDT
PRESS RELEASESContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer Inc.By GlobeNewswireMay 26, 2020 7:30 AM EDT
PRESS RELEASESPfizer Inc. Recommends Rejection Of Unsolicited Note Tender Offer By Huguenot Bond Liquidity, LLCBy Business WireMay 22, 2020 4:30 PM EDT
INVESTINGAstraZeneca Gets $1B From U.S. Government for Coronavirus VaccineBy M. Corey GoldmanMay 21, 2020 10:10 AM EDT
INVESTINGModerna Seeks New Stock Offering as Vaccine ProgressesBy M. Corey GoldmanMay 19, 2020 11:22 AM EDT
INVESTINGNovavax Shares Climb as B. Riley FBR Raises Price TargetBy Rob LenihanMay 18, 2020 10:14 AM EDT
PRESS RELEASESPfizer's New Phase 1b Results Of Gene Therapy In Ambulatory Boys With Duchenne Muscular Dystrophy (DMD) Support Advancement Into Pivotal Phase 3 StudyBy Business WireMay 15, 2020 8:00 AM EDT
PRESS RELEASESPfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study Of 20-Valent Pneumococcal Conjugate Vaccine In Pneumococcal Vaccine-Naive Adults 18 Through 49 Years Of AgeBy Business WireMay 14, 2020 10:00 AM EDT
JIM CRAMERSelling Squall: Cramer's 'Mad Money' Recap (Wednesday 5/13/20)By Scott RuttMay 13, 2020 8:57 PM EDT
PRESS RELEASESSave The Date: Pfizer Announces New Date Of September 14, 2020 For Rescheduled Investor DayBy Business WireMay 13, 2020 10:00 AM EDT
PRESS RELEASESPfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare ConferenceBy Business WireMay 12, 2020 10:00 AM EDT
PRESS RELEASESPfizer Invites Public To View And Listen To Webcast Of May 15 Conference Call With Analysts To Review Duchenne Muscular Dystrophy (DMD) Data Presentation At ASGCT 2020 Annual MeetingBy Business WireMay 8, 2020 10:00 AM EDT
INVESTINGGilead in Talks With Chemical and Pharma Makers on Global Remdesivir ProductionBy Tom BemisMay 5, 2020 6:31 PM EDT
MARKETSStocks End Higher as Lockdowns Are Eased and Oil Prices RallyBy Joseph WoelfelMay 5, 2020 4:19 PM EDT
INVESTINGPfizer and BioNTech Launch Human Trials of Covid-19 VaccineBy Scott Van VoorhisMay 5, 2020 8:43 AM EDT
PRESS RELEASESPfizer And BioNTech Dose First Participants In The U.S. As Part Of Global COVID-19 MRNA Vaccine Development ProgramBy GlobeNewswireMay 5, 2020 6:45 AM EDT
PRESS RELEASESPfizer And BioNTech Dose First Participants In The U.S. As Part Of Global COVID-19 MRNA Vaccine Development ProgramBy Business WireMay 5, 2020 6:45 AM EDT
PRESS RELEASESNew Data Suggest Burden Of Group B Streptococcus (GBS) Infection In U.S. Adults Greater Than Previously RecognizedBy Business WireMay 4, 2020 9:00 AM EDT
PRESS RELEASESAM Best Affirms Credit Ratings Of Blue Whale Re Ltd.By Business WireApr 30, 2020 10:16 AM EDT
